MicroRNA-204 targets JAK2 in breast cancer and induces cell apoptosis through the STAT3/BCl-2/survivin pathway.

作者: Xilong Wang , Guoqiang Zhang , Zhenlin Yang , Shujian Xu , Qiang Gao

DOI:

关键词: SurvivinCancer researchCancerApoptosisBiologyJanus kinase 2Cell growthBreast cancerCancer cellmicroRNA

摘要: MicroRNAs (miRNAs) have emerged as important regulators that potentially play critical roles in cancer cell biological processes. Previous studies shown miR-204 plays an role various human cancers. However, the underlying mechanisms of this microRNA breast remain largely unknown. In present study, we investigated expression level was markedly reduced both tissue and cultured lines (MCF-7, MDA-MB-231). Overexpression inhibited proliferation promoted apoptosis cells, which were reversed by co-transfection inhibitor. We validated Janus kinase 2 (JAK2), a direct target miR-204, is overexpressed cancer. Knockdown JAK2 suppressed viability induced cells. Moreover, negatively correlated with p-STAT3 anti-apoptotic genes BCl-2 surviving conclusions, targets p-JAK2 cancer, further inhibit activation STAT3, survivin. These findings indicate manipulation may represent novel therapeutic strategy treatment

参考文章(40)
Weidong Li, Xuejun Jin, Qianbing Zhang, Gong Zhang, Xubin Deng, Lei Ma, None, Decreased expression of miR-204 is associated with poor prognosis in patients with breast cancer. International Journal of Clinical and Experimental Pathology. ,vol. 7, pp. 3287- 3292 ,(2014)
Amit Verma, Suman Kambhampati, Simrit Parmar, Leonidas C Platanias, None, Jak family of kinases in cancer. Cancer and Metastasis Reviews. ,vol. 22, pp. 423- 434 ,(2003) , 10.1023/A:1023805715476
Cuijuan Qian, Jiji Wang, Jun Yao, Lan Wang, Meng Xue, Weili Liu, Jianmin Si, Involvement of nuclear JAK2 signaling in AG490-induced apoptosis of gastric cancer cells. Anatomical Record-advances in Integrative Anatomy and Evolutionary Biology. ,vol. 296, pp. 1865- 1873 ,(2013) , 10.1002/AR.22820
Lutfi Tutar, Esen Tutar, Yusuf Tutar, MicroRNAs and cancer; an overview. Current Pharmaceutical Biotechnology. ,vol. 15, pp. 430- 437 ,(2014) , 10.2174/1389201015666140519095304
Cui-Juan Qian, Jun Yao, Jian-Min Si, Nuclear JAK2: Form and Function in Cancer Anatomical Record-advances in Integrative Anatomy and Evolutionary Biology. ,vol. 294, pp. 1446- 1459 ,(2011) , 10.1002/AR.21443
A Sacconi, F Biagioni, V Canu, F Mori, A Di Benedetto, L Lorenzon, C Ercolani, S Di Agostino, A M Cambria, S Germoni, G Grasso, R Blandino, V Panebianco, V Ziparo, O Federici, P Muti, S Strano, F Carboni, M Mottolese, M Diodoro, E Pescarmona, A Garofalo, G Blandino, miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer Cell Death and Disease. ,vol. 3, ,(2012) , 10.1038/CDDIS.2012.160
S. Vimalraj, P. J. Miranda, B. Ramyakrishna, N. Selvamurugan, Regulation of breast cancer and bone metastasis by microRNAs. Disease Markers. ,vol. 35, pp. 369- 387 ,(2013) , 10.1155/2013/451248
Julio Vera, Katja Rateitschak, Falko Lange, Christina Kossow, Olaf Wolkenhauer, Robert Jaster, Systems biology of JAK-STAT signalling in human malignancies. Progress in Biophysics & Molecular Biology. ,vol. 106, pp. 426- 434 ,(2011) , 10.1016/J.PBIOMOLBIO.2011.06.013